Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1991 1
1992 2
1993 8
1994 29
1995 40
1996 65
1997 71
1998 83
1999 87
2000 96
2001 96
2002 144
2003 123
2004 132
2005 160
2006 170
2007 167
2008 186
2009 213
2010 245
2011 287
2012 289
2013 296
2014 322
2015 358
2016 318
2017 321
2018 346
2019 375
2020 387
2021 406
2022 374
2023 353
2024 346
2025 346

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,424 results

Results by year

Filters applied: . Clear all
Page 1
New Directions for Mantle Cell Lymphoma in 2022.
Kumar A, Eyre TA, Lewis KL, Thompson MC, Cheah CY. Kumar A, et al. Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-15. doi: 10.1200/EDBK_349509. Am Soc Clin Oncol Educ Book. 2022. PMID: 35561299 Free article.
Mantle cell lymphoma is a rare B-cell non-Hodgkin lymphoma that is clinically and biologically heterogeneous. ...One of the most powerful prognostic indices is the Mantle Cell Lymphoma International Prognostic Index-Combined, which integr …
Mantle cell lymphoma is a rare B-cell non-Hodgkin lymphoma that is clinically and biologically heterogeneous. ...One of …
Treatment approaches for patients with TP53-mutated mantle cell lymphoma.
Lew TE, Minson A, Dickinson M, Handunnetti SM, Blombery P, Khot A, Anderson MA, Ritchie D, Tam CS, Seymour JF. Lew TE, et al. Lancet Haematol. 2023 Feb;10(2):e142-e154. doi: 10.1016/S2352-3026(22)00355-6. Lancet Haematol. 2023. PMID: 36725119 Review.
Mantle cell lymphoma is an uncommon subtype of lymphoma characterised by clinical and biological heterogeneity. ...The poor outcomes for patients with TP53-mutated mantle cell lymphoma receiving chemoimmunotherapy and second-line Bruton t …
Mantle cell lymphoma is an uncommon subtype of lymphoma characterised by clinical and biological heterogeneity. ...The …
Blastoid Mantle Cell Lymphoma.
Jain P, Wang M. Jain P, et al. Hematol Oncol Clin North Am. 2020 Oct;34(5):941-956. doi: 10.1016/j.hoc.2020.06.009. Epub 2020 Aug 5. Hematol Oncol Clin North Am. 2020. PMID: 32861288 Review.
Blastoid and pleomorphic mantle cell lymphoma (MCL) are among the worst prognostic, aggressive histology, high-risk variants of MCL, and, in this article, they are presented as blastoid MCL. ...
Blastoid and pleomorphic mantle cell lymphoma (MCL) are among the worst prognostic, aggressive histology, high-risk var …
Mantle cell lymphoma and its management: where are we now?
Ladha A, Zhao J, Epner EM, Pu JJ. Ladha A, et al. Exp Hematol Oncol. 2019 Jan 30;8:2. doi: 10.1186/s40164-019-0126-0. eCollection 2019. Exp Hematol Oncol. 2019. PMID: 30733891 Free PMC article. Review.
Mantle cell lymphoma is a relatively new recognized hematological malignant disease, comprising of 2.5-6% non-Hodgkin's lymphomas. ...In a surprisingly short period of time, FDA specifically approved 4 drugs for treating mantle cell lymphoma …
Mantle cell lymphoma is a relatively new recognized hematological malignant disease, comprising of 2.5-6% non-Hodgkin's …
Mantle-cell lymphoma.
Barista I, Romaguera JE, Cabanillas F. Barista I, et al. Lancet Oncol. 2001 Mar;2(3):141-8. doi: 10.1016/S1470-2045(00)00255-2. Lancet Oncol. 2001. PMID: 11902564 Review.
During the past decade, mantle-cell lymphoma has been established as a new disease entity. The normal counterparts of the cells forming this malignant lymphoma are found in the mantle zone of the lymph node, a thin layer surrounding the germinal follicles. .. …
During the past decade, mantle-cell lymphoma has been established as a new disease entity. The normal counterparts of t …
Mantle cell lymphoma.
Pileri SA, Falini B. Pileri SA, et al. Haematologica. 2009 Nov;94(11):1488-92. doi: 10.3324/haematol.2009.013359. Haematologica. 2009. PMID: 19880776 Free PMC article. Review.
Pileri and Falini examines the diagnosis and bio-pathology of mantle cell lymphoma in the light of the criteria of the WHO Classification and recent reports. ...
Pileri and Falini examines the diagnosis and bio-pathology of mantle cell lymphoma in the light of the criteria of the …
Mantle cell lymphoma-Advances in molecular biology, prognostication and treatment approaches.
Silkenstedt E, Dreyling M. Silkenstedt E, et al. Hematol Oncol. 2021 Jun;39 Suppl 1:31-38. doi: 10.1002/hon.2860. Hematol Oncol. 2021. PMID: 34105823 Review.
Mantle cell lymphoma (MCL) is clinically characterized by its heterogenous behavior with courses ranging from indolent cases that do not require therapy for years to highly aggressive MCL with very limited prognosis. ...
Mantle cell lymphoma (MCL) is clinically characterized by its heterogenous behavior with courses ranging from indolent …
Mantle cell lymphoma.
Bertoni F, Zucca E, Cavalli F. Bertoni F, et al. Curr Opin Hematol. 2004 Nov;11(6):411-8. doi: 10.1097/01.moh.0000138682.13354.da. Curr Opin Hematol. 2004. PMID: 15548996 Review.
PURPOSE OF REVIEW: Mantle cell lymphoma is the B-cell lymphoma with the worst prognosis. Until now, no standard treatment has resulted in cure. ...SUMMARY: This review summarizes all the most recent data published on the biology and treatment of mantle …
PURPOSE OF REVIEW: Mantle cell lymphoma is the B-cell lymphoma with the worst prognosis. Until now, no standard treatme …
Hematopoietic cell transplantation for mantle cell lymphoma.
Yanada M, Yamamoto K. Yanada M, et al. Int J Hematol. 2022 Mar;115(3):301-309. doi: 10.1007/s12185-022-03294-z. Epub 2022 Jan 29. Int J Hematol. 2022. PMID: 35092557 Review.
Hematopoietic cell transplantation (HCT) represents a valuable therapeutic option for younger patients with mantle cell lymphoma (MCL). Despite the rarity of this disease, significant research efforts have been undertaken to improve the outcomes, and autologo …
Hematopoietic cell transplantation (HCT) represents a valuable therapeutic option for younger patients with mantle cell lym …
Mantle Cell Lymphoma: Current and Emerging Treatment Strategies and Unanswered Questions.
Diamond B, Kumar A. Diamond B, et al. Hematol Oncol Clin North Am. 2019 Aug;33(4):613-626. doi: 10.1016/j.hoc.2019.03.002. Epub 2019 May 7. Hematol Oncol Clin North Am. 2019. PMID: 31229158 Review.
Mantle cell lymphoma (MCL) is biologically and clinically heterogeneous with no clear standard of care. ...
Mantle cell lymphoma (MCL) is biologically and clinically heterogeneous with no clear standard of care. ...
6,424 results